NuCube Apr 2025 a Series of Regenr8 Master Fund LLC (CIK: 0002069574) EDGAR, Information, Filings... CompaniesBIO.Com

NuCube Apr 2025 a Series of Regenr8 Master Fund LLC

Mailing address
2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703
Phone
(360) 946-0604
State location
Delaware
State of incorporation
Delaware
Fiscal year end
December 31
SIC
N/A
Filings
N/A

NuCube Apr 2025 a Series of Regenr8 Master Fund LLC (CIK: 0002069574) is an American company incorporated in the state of Delaware. Head office is located at 2093 PHILADELPHIA PIKE, 5885, CLAYMONT, Delaware, 19703. Work in the industry N/A. NuCube Apr 2025 a Series of Regenr8 Master Fund LLC is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by NuCube Apr 2025 a Series of Regenr8 Master Fund LLC

Filings	Format	Description	Filed/Effective	File/Film Number
D	Document	Acc-no: 0002069574-25-000001 (33 Act) Size: KB	May-21-2025	021-546805 25972323

Recent 20 filings. View all NuCube Apr 2025 a Series of Regenr8 Master Fund LLC filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

NuCube Apr 2025 a Series of Regenr8 Master Fund LLC overview
NuCube Apr 2025 a Series of Regenr8 Master Fund LLC job
NuCube Apr 2025 a Series of Regenr8 Master Fund LLC stock
NuCube Apr 2025 a Series of Regenr8 Master Fund LLC ownership
NuCube Apr 2025 a Series of Regenr8 Master Fund LLC CEO
NuCube Apr 2025 a Series of Regenr8 Master Fund LLC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.